Leukemia & Lymphoma is an international peer reviewed journal that publishes research on all aspects of hematological malignancies.

The journal aims to address the needs of physicians and scientists interested in clinical, translational, laboratory and basic science research, as well as clinical diagnosis and treatment of patients with malignant hematological disorders.

Leukemia & Lymphoma covers from clinical and clinico-pathological investigations to fundamental research in the following topics:

    disease biology
    mechanisms of action of novel agents
    development of combination chemotherapy
    pharmacology and pharmacogenomics
    ethics and epidemiology

Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor.

The journal accepts original articles (clinical and research), review articles, letters to the editor, correspondence, commentaries, emerging drug profiles, clinical dilemmas.

The journal operates a double-anonymized peer review policy.